CRR Annual Newsletter - 2018
In the spirit of the season, I would like to take this opportunity to offer my sincere thanks for supporting the Columbia University Center for Radiological Research (CRR), a foremost leader in the study of radiation for the betterment of human health and national security. The success of the CRR’s threefold mission - to advance basic and medical research, educate the next generation of radiation health professionals, and advise government and the public on the risks and benefits of radiation use – continues to depend on supporters like you.
I am delighted to share with you a link to our 2018 year-end newsletter, highlighting progress made in three of the CRR’s major projects. From efforts that aim to revolutionize anti-bacterial and anti-viral technology, to studying the aftereffects of the Chernobyl nuclear disaster, to the launch of a new era in cancer radiotherapy, these projects hold great promise for preventing and treating many of today’s threats to human health. As a testament to their importance, these studies have recently received attention from national media outlets, including the Wall Street Journal, CBS Evening News, and Reuters.
Lastly, please mark your calendars for the Second Annual RARAF Benefit: Accelerating Radiation Therapy Research Toward a Cure for Cancer. Guests at the April 16, 2019 event will receive an insider’s view of the pioneering studies that have tremendous potential to change the way we fight cancer.
To access the newsletter, read our media coverage, or support our research efforts, please visit https://radiologicalresearch.net/2018. I invite you, as well, to consider making a year-end contribution now to underwrite those studies and ensure their continued vitality.
From all of us at the CRR, I wish you a fulfilling and joyous holiday season.
David J. Brenner
Director, Center for Radiological Research